by Dr. Jennifer Frangos, D.O., DABOM | Oct 15, 2026 | Insurance & Coverage, Testosterone Replacement Therapy
By Dr. Jennifer Frangos, D.O., DABOM. Published October 2026. Yes, in many cases. Aetna’s commercial medical policy considers testosterone cypionate medically necessary for specified diagnoses, including primary or hypogonadotropic hypogonadism with at least two...
by Dr. Jennifer Frangos, D.O., DABOM | May 20, 2026 | Insurance & Coverage, Guide, Testosterone Replacement Therapy
If your insurance denied progesterone, the issue is usually formulary restrictions, prior authorization, step therapy, or compounded medication exclusion — not necessarily a judgment that your treatment is inappropriate. Most progesterone denials can be addressed...
by Dr. Jennifer Frangos, D.O., DABOM | May 18, 2026 | Insurance & Coverage, Guide, Testosterone Replacement Therapy
Hormone replacement therapy costs in 2026 can range from very low out-of-pocket costs with strong insurance coverage to several hundred dollars per month for pellets, compounded medications, or non-covered therapies. The biggest cost differences usually come from...
by Dr. Jennifer Frangos, D.O., DABOM | May 10, 2026 | Insurance & Coverage, Guide, Testosterone Replacement Therapy
Compounded testosterone is usually not covered by insurance because compounded medications are not FDA-approved and generally are not included on insurance formularies. Retail testosterone products, however, often have a coverage pathway for men when documentation,...
by Dr. Jennifer Frangos, D.O., DABOM | May 9, 2026 | Insurance & Coverage, Guide, Testosterone Replacement Therapy
If your insurance suddenly stops covering a medication, it does not automatically mean you must stop treatment. Most mid-year coverage problems fall into a few categories: formulary changes, new prior authorization requirements, pharmacy network restrictions, or...
by Dr. Jennifer Frangos, D.O., DABOM | May 8, 2026 | Insurance & Coverage, Guide, Testosterone Replacement Therapy
Prior authorization is now a routine part of Medicare Advantage coverage. In 2024 alone, Medicare Advantage plans processed nearly 53 million prior authorization determinations, with about 4.1 million fully or partially denied. The important part: when denials were...
